FDA approves weight-loss drug Zepbound to treat sleep apnea - The Washington Post

1. FDA approves weight-loss drug Zepbound to treat sleep apnea  The Washington Post
2. F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea  The New York Times
3. FDA Approves First Medication for Obstructive Sleep Apnea  FDA.gov
4. FDA approves weight-loss drug Zepbound for obstructive sleep apnea  CNN
5. FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and Company